Application no. and date | 05784484.7 (espacenet) (Federated) (European Patent Register), 20050808 | Patent/reg. no. and date | DK/EP 1781688, 20110119 | Publication date | 20070509 | Priority no. and date | US 599401 P, 20040806, US 610001 P, 20040914, US 106879, 20050414 | EP pub. no. and date |
EP 1781688 20070509 | Effective date | | Applicant/owner | Onyx Therapeutics, Inc., 249 E. Grand Avenue South San Francisco, CA 94080, US | Applicant ref. no. | 140444 | Inventor | LAIDIG, Guy, J., 329 Waverley Street
Menlo Park, CA 94025, US, SMYTH, Mark, S., 700 East 19th Avenue, Apt 211
San Mateo, CA 94403, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 38/06 (2006.01) , A61K 38/07 (2006.01) , C07K 5/02 (2006.01) , C07K 5/087 (2006.01) , C07K 5/103 (2006.01) | Title | Forbindelser til proteasomenzyminhibering | Int. application no. | US2005028246 | Int. publication no. | WO2006017842 | Related patent (certificate) | CA 2016 00014 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|